Subscribe
Home
Issues
Latest Issue
Issue Archive
Special Issues
Categories
Web Exclusives
Web Exclusive Articles
Webinars
Search ...
VBCN - April 2016 Volume 3, No 1
Medical Costs, Lost Productivity Are Substantial for Chronic Migraine
By
Wayne Kuznar
Migraine
VBCN - April 2016 Volume 3, No 1
The annual direct medical costs of patients with chronic migraine approach $5000, and the costs associated with lost productivity exceed $3000 annually.
Read More
Assessing the Value of Neurologist-Directed Patient Care
By
Charles Bankhead
Health Economics
VBCN - April 2016 Volume 3, No 1
Neurologist-directed ambulatory care for chronic neurologic diseases resulted in higher costs but fewer adverse events and less use of acute care services, according to an American Academy of Neurology–supported study.
Read More
Drug-Refractory Tardive Dyskinesia Improves with Deep-Brain Stimulation
By
Charles Bankhead
Tardive Dyskinesia
VBCN - April 2016 Volume 3, No 1
Patients with drug-refractory tardive dyskinesia had significant and durable symptomatic improvement after bilateral deep-brain stimulation, a small clinical study showed.
Read More
Ocrelizumab Receives Breakthrough Therapy for Progressive Multiple Sclerosis
By
Caroline Helwick
Multiple Sclerosis
VBCN - April 2016 Volume 3, No 1
The monoclonal antibody ocrelizumab was recently granted a breakthrough therapy designation by the FDA for the treatment of patients with primary progressive multiple sclerosis (PPMS).
Read More
Ozanimod Achieves Very Low Relapse Rate in MS
By
Caroline Helwick
Multiple Sclerosis
VBCN - April 2016 Volume 3, No 1
Ozanimod, an oral modulator of the sphingosine1-phosphate (S1P) receptor, was effective up to 72 weeks in a blinded extension of the phase 2/3 RADIANCE clinical trial that included patients with relapsing forms of multiple sclerosis (MS).
Read More
Stem-Cell Transplantation Shows Promise in Multiple Sclerosis, but Major Concerns Remain
By
Caroline Helwick
Multiple Sclerosis
VBCN - April 2016 Volume 3, No 1
Could stem-cell transplantation prove equally efficacious and more cost-effective than the currently available and expensive drugs for multiple sclerosis (MS)? Experts weighed in on this topic at ACTRIMS Forum 2016, a recent meeting of the Americas Committee for Treatment and Research in Multiple Sclerosis.
Read More
New Migraine Screening Tool Shows Promise
By
Laura Morgan
Migraine
VBCN - April 2016 Volume 3, No 1
Migraine is the third most common medical condition and the eighth leading cause of disability worldwide, according to the World Health Organization; yet, migraines are still underdiagnosed and undertreated. The misdiagnosis of migraines is partly to blame for patients not receiving optimal care.
Read More
In The Literature - April 2016
In the Literature
VBCN - April 2016 Volume 3, No 1
Natalizumab Shows Efficacy versus Fingolimod in Relapsing-Remitting Multiple Sclerosis
Accuracy of Parkinson’s Disease Clinical Diagnosis Is Suboptimal
Study Examines Serious Adverse Events with Long-Term Sumatriptan in Patients with Chronic Cluster Headache
Read More
CSF Biomarkers and Amyloid PET Equally Accurate in Identifying Early-Stage Alzheimer’s Disease
By
Wayne Kuznar
Alzheimer’s Disease/Dementia
VBCN - April 2016 Volume 3, No 1
Cerebrospinal fluid (CSF) biomarkers and cerebral beta-amyloid and amyloid positron emission tomography (PET) measures are equally accurate in the identification of early Alzheimer’s disease.
Read More
BDNF Gene Expression Slows Cognitive Decline in Alzheimer’s Disease
By
Laura Morgan
Alzheimer’s Disease/Dementia
VBCN - April 2016 Volume 3, No 1
Significant strides have been made in understanding the factors that influence cognitive decline in older adults. Multiple studies have found that the brain-derived neurotrophic factor (BDNF) may play a role in late-life cognitive impairment, particularly in the pathogenesis of Alzheimer’s disease. For example, beta-amyloid, which is increased in Alzheimer’s disease, may interact with BDNF and suppress its expression, resulting in impaired cognition.
Read More
Page 1 of 2
1
2
Search ...
Home
Issues
Latest Issue
Issue Archive
Special Issues
Categories
Web Exclusives
Web Exclusive Articles
Webinars
Subscribe to
Value-Based Care in Neurology
Stay up to date with personalized medicine by subscribing to receive the free
VBCN
e‑Newsletter.
I'd like to receive:
VBCN
e‑Newsletter
I have reviewed and consent to the terms of
VBCN
's
Privacy Policy
, and
VBCN
has my permission to retain my information in its database, and to forward pertinent communications to me.